english.prescrire.org > Prescrire International > N°67 - October 2003

n°67

October 2003

Issue Contents
Editorial

Agalsidase evaluation: a case in point

p.162

New Products


Imatinib: efficacy in gastrointestinal stromal tumours must be confirmed

p.163-164

Thalidomide: a last resort in myeloma

p.165-167

Thalidomide: a painfully instructive history

p.167

Agalsidase with hindsight: full data challenge efficacy

p.168-171

Levocetirizine me-too: simply the active enantiomer of cetirizine

p.171-172

Timolol + latanoprost: last resort eye drops

p.173-174

Paroxetine in generalised anxiety: uncertain efficacy

p.175-177

Paracetamol for injection, new formulation: why so widely used?

p.178

Sublingual selegiline, new formulation: new risk of oral adverse effects

p.179

Zoledronic acid

p.180

Follitropin beta

p.180

Somatropin

p.180

Rasburicase

p.180

Botulinum toxin type A

p.180

Adverse Effects


Phaechromocytoma unmasked by drug therapy

p.181-182

Low-molecular-weight heparin and thrombocytosis

p.183

Loratadine, desloratadine and pregnancy

p.183

Haemorrhagic cystitis with ticarcillin

p.183

Mania induced by antimicrobial agents

p.183

Reviews


Acute otitis media in children: amoxicillin remains the standard antibiotic, but justified in certain situations only

p.184-189

Acute uncomplicated cystitis in women

p.190

Rhabdomyolysis

p.190

Tumour lysis syndrome

p.190

Treatment of open-angle glaucoma

p.190

Outlook


Essential drugs: WHO back on course

p.191

Reorienting the course of medicines policy: actions are bearing fruit

p.192-194

EU lobbies : Les eaux blessées

p.194

French drug refunding policy is bad

p.195

Who is benefiting?

p.195

Custom-made evaluation

p.195

No thanks to sales reps: Healthy Skepticism

p.196

No thanks to sales reps: No Free Lunch

p.197

No thanks to sales reps: news of the Prescrire Network

p.197

Forum


Open letter to our northern brothers

p.198

Heparin prevention during hospitalisation in medical wards?

p.198-199

Unethical clinical trials?

p.199

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe